We are live on ! Find out more
ACIU icon

AC Immune

42 hedge funds and large institutions have $137M invested in AC Immune in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

2% less capital invested

Capital invested by funds: $139M → $137M (-$2.16M)

1.49% less ownership

Funds ownership: 29.86%28.37% (-1.5%)

16% less funds holding

Funds holding: 5042 (-8)

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

Holders
42
Holders Change
-8
Holders Change %
-16%
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
4
Increased
17
Reduced
10
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Mackenzie Financial
51
Mackenzie Financial
Ontario, Canada
-$77K -11,100 Closed
DWA
52
Dorsey Wright & Associates
California
-$9K -1,324 Closed
Bank of America
53
Bank of America
North Carolina
-$5K -750 Closed
ASN
54
Advisory Services Network
Georgia
-$4K -600 Closed

ACIU Hedge Fund Activity: Q2 2020 in Review

42 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2020, worth a combined $137M — down 1.5% from $139M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ACIU and 4 opened new positions — a net loss of 8 holders — while 10 trimmed existing stakes and 17 added.

The largest buyer was BlackRock, adding an estimated $1.19M. The largest seller was QS Investors, exiting entirely with an estimated $854K sold.

  • 42 institutional investors held AC Immune (ACIU) as of Q2 2020, down from 50 in Q1 2020.
  • Funds reported $137M of AC Immune stock for Q2 2020, down 1.5% quarter-over-quarter.
  • 4 funds opened new AC Immune positions in Q2 2020 and 12 closed out, a net change of -8 holders.
  • The largest AC Immune buyer in Q2 2020 was BlackRock, an estimated $1.19M added.
  • The largest AC Immune seller in Q2 2020 was QS Investors, an estimated $854K sold.

Based on aggregated 13F filings for Q2 2020.